⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

January 1, 2021Cancer Drug ResistanceOpen Access

Liposome co-encapsulation of anti-cancer agents for pharmacological optimization of nanomedicine-based combination chemotherapy

Alberto Gabizón Patricia Ohana Yasmine Amitay Jenny Gorin Dina Tzemach Lidia Mak Hilary Shmeeda

View Full Paper

Ask AI

Bookmark

Share

Abstract

: PLAD-MLP is a novel multi-drug liposome formulation with attractive pharmacological properties and powerful antitumor activity and is a promising therapeutic tool for combination cancer chemotherapy.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Gabizón et al. (2021) studied this question.

synapsesocial.com/papers/69f44a8d39b6a8ca1e206f43 https://doi.org/10.20517/cdr.2020.87

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 related papers. Consider them for comparative context:

1PSMD14 as a translational target in cancer and beyond: from deubiquitination mechanisms to drug resistance and precision therapyCancer Drug Resistance · Mon,
2Resistance to third-generation EGFR TKIs - what can be expected from the fourth-generation?Cancer Drug Resistance · Thu,
3Bracing for the storm: emerging resistance mechanisms to KRAS inhibitors in pancreatic cancer and strategies to overcome themCancer Drug Resistance · Mon,
4Adenylosuccinate lyase in pancreatic ductal adenocarcinoma chemoresistance: from purine metabolism to metabolic vulnerabilityCancer Drug Resistance · Mon,
5Mitochondrial LINC01133 regulates pyroptosis and calcium homeostasis in cisplatin-resistant lung adenocarcinomaCancer Drug Resistance · Tue,

More from Cancer Drug Resistance

TET2 downregulation limits oxidative stress-induced cytotoxicity of high dose ascorbate in dabrafenib-resistant melanoma cellsMon,
Mechanistic roles and clinical applications of tertiary lymphoid structures in colorectal cancer drug resistanceTue,
An epithelial-mesenchymal transition-related gene signature predicts prognosis, immune infiltration, and drug sensitivity in colorectal cancerMon,
Lack of resolution of inflammation marks malignant pleural mesothelioma progressionThu,
LINC01607 promotes hepatocellular carcinoma progression and ferroptosis-associated therapy resistance with functional involvement of the p62–Keap1–Nrf2 pathwayFri,